173 related articles for article (PubMed ID: 34385184)
1. Radiation-Induced Phosphorylation of a Prion-Like Domain Regulates Transformation by FUS-CHOP.
Chen M; Foster JP; Lock IC; Leisenring NH; Daniel AR; Floyd W; Xu E; Davis IJ; Kirsch DG
Cancer Res; 2021 Oct; 81(19):4939-4948. PubMed ID: 34385184
[TBL] [Abstract][Full Text] [Related]
2. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
[TBL] [Abstract][Full Text] [Related]
3. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
[TBL] [Abstract][Full Text] [Related]
4. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
[TBL] [Abstract][Full Text] [Related]
5. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.
Ryan JJ; Sprunger ML; Holthaus K; Shorter J; Jackrel ME
J Biol Chem; 2019 Jul; 294(29):11286-11296. PubMed ID: 31171724
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic transcription factor FUS-CHOP can undergo nuclear liquid-liquid phase separation.
Owen I; Yee D; Wyne H; Perdikari TM; Johnson V; Smyth J; Kortum R; Fawzi NL; Shewmaker F
J Cell Sci; 2021 Sep; 134(17):. PubMed ID: 34357401
[TBL] [Abstract][Full Text] [Related]
7. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma.
Patil N; Ahmed Kabeer Rasheed S; Abba M; Hendrik Leupold J; Schwarzbach M; Allgayer H
Int J Cancer; 2014 Jun; 134(12):2808-19. PubMed ID: 24285420
[TBL] [Abstract][Full Text] [Related]
8. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.
Tornin J; Hermida-Prado F; Padda RS; Gonzalez MV; Alvarez-Fernandez C; Rey V; Martinez-Cruzado L; Estupiñan O; Menendez ST; Fernandez-Nevado L; Astudillo A; Rodrigo JP; Lucien F; Kim Y; Leong HS; Garcia-Pedrero JM; Rodriguez R
Neoplasia; 2018 Jan; 20(1):44-56. PubMed ID: 29190494
[TBL] [Abstract][Full Text] [Related]
9. FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.
Davis RB; Kaur T; Moosa MM; Banerjee PR
Protein Sci; 2021 Jul; 30(7):1454-1466. PubMed ID: 34018649
[TBL] [Abstract][Full Text] [Related]
10. Role of FUS-CHOP in Myxoid Liposarcoma via miR-486/CDK4 Axis.
Wu H; Xia L; Xu H
Biochem Genet; 2022 Jun; 60(3):1095-1106. PubMed ID: 34792704
[TBL] [Abstract][Full Text] [Related]
11. Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation.
Rodriguez R; Tornin J; Suarez C; Astudillo A; Rubio R; Yauk C; Williams A; Rosu-Myles M; Funes JM; Boshoff C; Menendez P
Stem Cells; 2013 Oct; 31(10):2061-72. PubMed ID: 23836491
[TBL] [Abstract][Full Text] [Related]
12. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
[TBL] [Abstract][Full Text] [Related]
13. DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2.
Bento C; Andersson MK; Aman P
BMC Cell Biol; 2009 Dec; 10():89. PubMed ID: 20017906
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development.
Ranji P; Jonasson E; Andersson L; Filges S; Luna Santamaría M; Vannas C; Dolatabadi S; Gustafsson A; Myklebost O; Håkansson J; Fagman H; Landberg G; Åman P; Ståhlberg A
J Transl Med; 2024 Apr; 22(1):389. PubMed ID: 38671504
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of trabectedin in myxoid liposarcomas.
Di Giandomenico S; Frapolli R; Bello E; Uboldi S; Licandro SA; Marchini S; Beltrame L; Brich S; Mauro V; Tamborini E; Pilotti S; Casali PG; Grosso F; Sanfilippo R; Gronchi A; Mantovani R; Gatta R; Galmarini CM; Sousa-Faro JM; D'Incalci M
Oncogene; 2014 Oct; 33(44):5201-10. PubMed ID: 24213580
[TBL] [Abstract][Full Text] [Related]
16. A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression.
Oikawa K; Tanaka M; Itoh S; Takanashi M; Ozaki T; Muragaki Y; Kuroda M
Br J Cancer; 2012 Jun; 106(12):1976-9. PubMed ID: 22588557
[TBL] [Abstract][Full Text] [Related]
17. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
[TBL] [Abstract][Full Text] [Related]
18. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
[TBL] [Abstract][Full Text] [Related]
19. [Current idea of the morphogenetic features of liposarcomas].
Todorov SS; Kit OI
Arkh Patol; 2012; 74(6):61-3. PubMed ID: 23383449
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
